{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:35:51Z","timestamp":1793424951368,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008363","name":"Danish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.radonc.2026.111851","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:53:42Z","timestamp":1792652022000},"page":"111851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["QART or SMART? Expanding quality assurance into the safe Management, assurance and reporting of radiotherapy techniques"],"prefix":"10.1016","author":[{"given":"Orit","family":"Kaidar-Person","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesbeth J.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Icro","family":"Meattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte V.","family":"Offersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111851_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111096","article-title":"Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial","volume":"211","author":"Hansen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110284","article-title":"Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin","volume":"196","author":"Zukauskaite","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0015","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2340\/1651-226X.2025.43924","article-title":"Late dysphagia after changes in high-dose clinical tumour volume margin for head and neck cancer patients","volume":"64","author":"Zukauskaite","year":"2025","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0020","series-title":"Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology","article-title":"Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. a 30-year long-term report from the danish breast cancer cooperative group DBCG 82bc trial","author":"Overgaard","year":"2022"},{"key":"10.1016\/j.radonc.2026.111851_b0025","unstructured":"Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14\u2009324 women in 16 trials. Lancet. 2023;402:1991-2003."},{"issue":"3","key":"10.1016\/j.radonc.2026.111851_b0071","article-title":"Twenty-year results of the randomized European Organization for Research and Treatment of Cancer trial 22922\/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer","volume":"76","author":"Kaidar-Person","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2026.111851_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111035","article-title":"Repositioning radiation oncology at the centre of integrated oncology care: a manifesto of the European society for radiotherapy and oncology (ESTRO)","volume":"210","author":"Meattini","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0035","article-title":"Internal mammary node irradiation in 4541 node-positive breast cancer patients treated with newer systemic therapies and 3D-based radiotherapy (DBCG IMN2): a prospective, nationwide, population-based cohort study. the Lancet Regional Health \u2013","volume":"49","author":"Nielsen","year":"2025","journal-title":"Europe"},{"issue":"4","key":"10.1016\/j.radonc.2026.111851_b0072","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1200\/JCO.2015.63.6456","article-title":"DBCG-IMN: A Population-Based Cohort Study on the Effect of Internal Mammary Node Irradiation in Early Node-Positive Breast Cancer","volume":"34","author":"Thorsen","year":"2016","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.radonc.2026.111851_b0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110600","article-title":"Quality assurance of internal mammary node irradiation in the DBCG IMN2 study","volume":"202","author":"Refsgaard","year":"2025","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2026.111851_b0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.breast.2016.05.004","article-title":"Helical tomotherapy for bilateral breast cancer: Clinical experience","volume":"28","author":"Kaidar-Person","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.radonc.2026.111851_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110700","article-title":"Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques","volume":"204","author":"Vincenzi","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.radonc.2022.09.024","article-title":"Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial","volume":"177","author":"Thomsen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110574","article-title":"Breast induration and irradiated volume in the DBCG HYPO trial: the impact of age, smoking, and boost","volume":"201","author":"Thomsen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110849","article-title":"Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial","volume":"207","author":"Brion","year":"2025","journal-title":"Radiotherapy and Oncology"},{"issue":"10532","key":"10.1016\/j.radonc.2026.111851_b0075","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0140-6736(25)02597-8","article-title":"5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial","volume":"407","author":"Rivera","year":"2026","journal-title":"The Lancet"},{"key":"10.1016\/j.radonc.2026.111851_b0076","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1200\/JCO-25-02705","article-title":"Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1","volume":"44","author":"Offersen","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/02841860902824917","article-title":"Hypofractionation in radiotherapy. An investigation of injured Swedish women, treated for cancer of the breast","volume":"48","author":"Friberg","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111547","article-title":"Factors associated with arm swelling in patients undergoing surgery and radiotherapy for breast cancer within the FAST-Forward trial nodal sub-study","volume":"220","author":"Ravindra","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0077","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110372","article-title":"Quality assessment of radiotherapy in the prospective randomized SENOMAC trial","volume":"197","author":"Alkner","year":"2024","journal-title":"Radiotherapy and Oncology"},{"key":"10.1016\/j.radonc.2026.111851_b0070","article-title":"Essential requirements for reporting radiation therapy in breast cancer clinical trials: an international multi-disciplinary consensus endorsed by the European Society for Radiotherapy and Oncology (ESTRO)","author":"Kaidar-Person","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111851_b0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111594","article-title":"Validation of the ESTRO target volume consensus guideline for early-stage breast cancer in the DBCG Skagen Trial 1","volume":"221","author":"H\u00f8gsbjerg","year":"2026","journal-title":"Radiotherapy and Oncology"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026006912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:28:41Z","timestamp":1793424521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026006912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S0167814026006912"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111851","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"QART or SMART? Expanding quality assurance into the safe Management, assurance and reporting of radiotherapy techniques","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111851"}}